Chandigarh, Aug. 1 -- Researchers at Panjab University (PU) have been granted an Indian patent for a novel natural biomolecule with potential anti-cancer properties. The patent recognises their work on a biosurfactant derived from an endophytic bacterium that has shown promising results against acute T-cell leukemia cells in laboratory studies. The research team comprises Rohit Sharma, professor in the biotechnology department, Monika Sharma and alumnus and former research scholar Shruti Nagrath of microbial biotechnology. Their patented innovation is titled "Exploring the anti-cancer efficacy of endophytic bacillus safensis-derived rhamnolipid (a biosurfactant) on acute t-cell leukemia cells." The patent has been awarded by the Indian Patent Office, recognising their pioneering contribution to the discovery and development of anti-cancer compounds against leukemia. Key strengths of the innovation include its natural origin, selective efficacy against specific leukemia cell lines, scalability of the purification process, and strong potential for pharmaceutical formulation and commercial development. Collectively, these attributes position the technology as a promising candidate for developing next-generation anti-cancer therapeutics. "This patent showcases PU's efforts to turn scientific research into practical healthcare solutions. Our findings open new directions for safer, more sustainable, and biologically inspired cancer treatments," said Sharma....